Skip to main content
. 2018 Nov 1;13(1):11–19. doi: 10.1177/1932296818807223

Table 4.

Comparison of Basal-Bolus Delivery Methods.

Pens and needles PAQ® V-Go® OmniPod® Paradigm Revel™
Wearable device Wearable device Wearable pump—PDM for programming Infusion set tethered to programmable pump
graphic file with name 10.1177_1932296818807223-img1.jpg graphic file with name 10.1177_1932296818807223-img2.jpg graphic file with name 10.1177_1932296818807223-img3.jpg graphic file with name 10.1177_1932296818807223-img4.jpg graphic file with name 10.1177_1932296818807223-img5.jpg graphic file with name 10.1177_1932296818807223-img6.jpg

Simple
No. of training visits 1 1a (within 60  minutes) Data not available 2-3b (2-3  hours/visit) 2-3b (2-3  hours/visit)
Needle sticks ⩾2 to 9c per day Cannula placed every 3 days Needle placed once per day Cannula placed once every 3 days Cannula placed once every 3 days
Insulin administered Rapid, intermediate
Long-acting
Mixtures
One—Rapid-acting
Discreet
Dosing No Yes—worn under clothing
Notification of insulin flow NA Yes—through vibration NA No—audible alarm No—audible alarm
Safe and effective insulin delivery
Mode of basal insulin delivery Large volume injection CSIId CSIId CSIId CSIId
Reservoir volume NA 140-330e 76 U/day, 36 U for bolus, 20-40 basal 85-200 176-300
Basal delivery NA 7 preset rates 3 preset rates Programmable rates Programmable rates
Bolus increment (units) One injection at each meal 2 /push of button 2 /push of button Programmable: 0.05, 0.1, 0.5, or 1.0 Programmable: 0.025, 0.05, or 0.10
Satisfaction Nof Yesc Yesg Yesh Yesi
Out of insulin/occlusion detection NA Yes (vibration) No Yes (alarm) Yes (alarm)
a.

PAQ insulin delivery device summative human factors study report CQR-15008-02.

b.

CeQur interviews with diabetes educators.

c.

Mader J, et al. Diabet Med. 2018. Published online: June 11, 2018 (doi:10.1111/dme.13708. PMID: 29888811).

d.

Parkner T, et al. Diabet Med. 2008;25:585-591.

e.

Fill volume is dependent upon the amount needed over 3 days by the user.

f.

Peyrot M, et al. Diabetes Care. 2010;33(2):240-245.

g.

Rosenfeld C, et al. Endocr Pract. 2012;18(5):660-667.

h.

Polonsky W, et al. Diabetes Technol Ther. 2016;18(10):664-670.

i.

Raskin P, et al. Diabetes Care 2003;26:2598-2603; Aronson R, et al. Diabetes Technol Ther. 2015;17(Supp 1):A11.